From India to the World — A Better Way to Prevent Cervical Cancer

Abstract

In this issue of the Journal, Sankaranarayanan et al.¹ report the results of a randomized clinical trial of screening for cervical cancer involving more than 130,000 women in India. The authors conclusively showed that a single round of screening for human papillomavirus (HPV) dramatically reduced the incidence of advanced cervical cancer and cervical-cancer mortality within 8 years far more than a single conventional cytologic test or visual inspection of the cervix with acetic acid (VIA).